With CRISPR gene editing, unique treatments begin to take off for rare diseases

CRISPR can help patients with rare diseases such as transthyretin (ATTR) amyloidosis, which otherwise is a “truly awful, gradually progressive disease that is ultimately fatal,” says Professor Julian Gillmore (UCL Medicine).

Read: Washington Post